DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 1.20% to $8.23 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.50% to 23,474.35 and Dow Jones Industrial Average falling 0.51% to 48,461.93.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 59.97% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 2.27% to $7.20, Fortress Biotech Inc. (FBIO) fell 4.28% to $3.58, and Viking Therapeutics Inc. (VKTX) fell 1.94% to $36.46.
Trading volume (221,979) remained 292,689 below its 50-day average volume of 514,668.
Data source: Dow Jones Market Data, FactSet. Data compiled December 29, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 29, 2025 17:22 ET (22:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments